BrainCool
1,83 SEK +12,13%4 investorer følger denne virksomhed
BrainCool develops products used for medical cooling of the human brain. The technology acts as cooling pads that are applied to different part of the patient's body, where the system controls the body temperature and other movements. The products are used in the treatment of various severe conditions such as stroke, cardiac arrest, concussion, and migraine. BrainCool was founded in 2010 and is based in Lund.
Omsætning
23,23 mio.
EBIT %
-233,15 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
BRAIN
Daglig lav / høj pris
1,61 / 1,92
SEK
Markedsværdi
463,71 mio. SEK
Aktieomsætning
906,17 t SEK
Volumen
527 t
Seneste videoer
Finanskalender
Generalforsamling
26.06.2024
Delårsrapport
15.08.2024
Delårsrapport
01.11.2024
Årsrapport
03.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Avanza Pension | 10,8 % | 10,8 % |
Landia AB | 7,5 % | 7,5 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
BrainCool AB (publ) publishes prospectus due to the upcoming rights issue
BrainCool AB (publ) carries out a rights issue of SEK 85.8 million
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools